(100 days)
Spacelabs Healthcare Capnography Pod, Model 92516,Spacelabs Healthcare Capnography Pod (92516),Qube Compact Monitor (91390)
No
The document describes a standard capnography device that measures CO2 and respiratory rate. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies.
No
The device is described as a "Capnography Pod" intended for "monitoring carbon dioxide and respiration rate" and alerting clinical personnel. It provides measurements and displays information, but it does not treat or cure any medical condition.
No
The device is intended for monitoring and alerting clinical personnel, not for diagnosing conditions.
No
The device description clearly states it is a "modular unit" and a "sidestream analyzer," which are hardware components. It also mentions being "attached to the pod connection" of another hardware device (Qube). While software is involved for control and display, the core function relies on physical hardware for gas analysis.
Based on the provided information, the Spacelabs Healthcare Capnography Pod, Model 92516 (CapnoPod) is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is to monitor carbon dioxide and respiration rate in patients. This is a physiological measurement taken directly from the patient's breath, not a test performed on a sample of biological material outside the body.
- Device Description: The device is described as a "sidestream analyzer" that measures CO2 and respiratory rate. This aligns with monitoring physiological parameters in a living subject.
- Lack of IVD Characteristics: The description does not mention analyzing biological samples (like blood, urine, tissue, etc.) or providing information about a patient's health status based on such analysis.
IVD devices are specifically designed to perform tests on biological samples to provide information for diagnosis, monitoring, or screening. The CapnoPod's function is to directly measure a physiological parameter from the patient's breath.
N/A
Intended Use / Indications for Use
The Spacelabs Healthcare Capnography Pod, Model 92516 (CapnoPod) is intended to provide a means of monitoring carbon dioxide and respiration rate and alert clinical personnel when the concentration moves outside of user-defined limits.
The CapnoPod is intended to be used with and controlled by a Spacelabs Healthcare monitors. The CapnoPod is intended to be used for monitoring adult, pediatric and neonate patients, under the direction of qualified medical personnel.
Product codes
CCK
Device Description
The Spacelabs Healthcare Capnography Pod (92516) (CapnoPod) is an easy-to-use modular unit in the Spacelabs Healthcare family of monitors). The CapnoPod is attached to the pod connection on the rear of a Qube Compact Monitor (91390) (Qube). The Qube is then used to control the CapnoPod, and provide the user interface for the CapnoPod.
The CapnoPod is a sidestream analyzer intended to provide a measurement of the following parameters: carbon dioxide (CO2); and respiratory rate.
The Qube displays information from the CapnoPod and is the user interface for the CapnoPod. The Qube provides a number display for CO2 and respiratory rate, and a capnograph waveform. The CapnoPod is intended to be used primarily in the operating room environment.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult, pediatric and neonate patients
Intended User / Care Setting
qualified medical personnel. The CapnoPod is intended to be used primarily in the operating room environment.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Electrical Safety: The CapnoPod was tested for performance in accordance with the following Standards: IEC 60601-1: 1988, Am1: 1991, Am2: 1995, Medical electrical equipment - Part 1. General requirements for safety; and UL 60601-1: 2003, Medical electrical equipment - Part 1. General requirements for safety. Test results indicated that the CapnoPod complies with the Standards.
Electromagnetic Compatibility (EMC) Testing: The CapnoPod was tested for performance in accordance with the following Standard: IEC 60601-1-2: 2007, Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance – Collateral standard: Electromagnetic compatibility – Requirements and tests. Test results indicated that the CapnoPod complies with the Standards.
Software Testing: Software device modifications made to the CapnoPod were designed and developed according to a robust software development process, and were rigorously verified and validated. Software information is provided in accordance with internal documentation and the following Standards and guidance documents: FDA guidance: The content of premarket submissions for software contained in medical devices, 11 May 05; FDA guidance: Off-the-shelf software use in medical devices, 09 Sep 99; FDA guidance: General principles of software validation; Final guidance for industry and FDA staff, 11 Jan 02; IEC 60601-1-4: 2000, Medical electrical equipment Medical electrical equipment - Part 1-4: General requirements for safety – Collateral Standard: Programmable electrical medical systems. Test results indicate that the CapnoPod complies with its predetermined specification and the Standards and guidance documents.
Performance Testing: The CapnoPod was tested for performance in accordance with internal documentation and the following Standards: IEC 60601-1-8: 2006, Medical electrical equipment – Part 1-8: General requirements for basic safety and essential performance – Collateral Standard: General requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical systems; and ISO 21647: 2004, Medical electrical equipment – Particular requirements for the basic safety and essential performance of respiratory gas monitors. Test results indicated that the CapnoPod complies with its predetermined specification and with the applicable Standards.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.1400 Carbon dioxide gas analyzer.
(a)
Identification. A carbon dioxide gas analyzer is a device intended to measure the concentration of carbon dioxide in a gas mixture to aid in determining the patient's ventilatory, circulatory, and metabolic status. The device may use techniques such as chemical titration, absorption of infrared radiation, gas chromatography, or mass spectrometry.(b)
Classification. Class II (performance standards).
0
510(k) Summary
| Submission Date: | 21 March 2012 | JUL 13 2012 | ||
|---|---|---|---|---|
| Submitter: | Spacelabs Healthcare | |||
| 5150 220th Avenue SE | ||||
| Issaquah, WA 98029 | ||||
| Submitter Contact: | Spacelabs Healthcare | |||
| 5150 220th Avenue SE | ||||
| Issaquah, WA 98029 | ||||
| Mr. David J. Geraghty | ||||
| Spacelabs Healthcare | ||||
| Phone: +1 (425) 657-7200, ext 5889 | ||||
| Fax: +1 (425) 657-7210 | ||||
| Email: david.geraghty@spacelabs.com | ||||
| Official Contact: | Thomas Kroenke | |||
| Principal Consultant | ||||
| Speed To Market, Inc. | ||||
| PO Box 3018 | ||||
| Nederland, CO 80466 USA | ||||
| tkroenke@speedtomarket.net | ||||
| 303 956 4232 | ||||
| Manufacturing Site: | Spacelabs Healthcare | |||
| 5150 220th Avenue SE | ||||
| Issaquah, WA 98029 | ||||
| Trade Name: | Spacelabs Healthcare Capnography Pod (92516) | |||
| Common Name: | CO2 monitor | |||
| Classification Name: | Carbon dioxide gas analyzer | |||
| Classification | ||||
| Regulation: | 21 CFR §868.1400 | |||
| Product Code: | CCK | |||
| Substantially | ||||
| Equivalent Devices: | New Spacelabs Model | Predicate | ||
| 510(k) Number | Predicate Manufacturer / Model | |||
| Spacelabs Healthcare | ||||
| Capnography Pod | ||||
| (92516) | K112173 | Spacelabs Multigas | ||
| Module, Model 92518 |
Page I of 4
1
510(k) Summary
The Spacelabs Healthcare Capnography Pod (92516) (CapnoPod) is an Device Description: easy-to-use modular unit in the Spacelabs Healthcare family of monitors). The CapnoPod is attached to the pod connection on the rear of a Qube Compact Monitor (91390) (Qube). The Qube is then used to control the CapnoPod, and provide the user interface for the CapnoPod.
The CapnoPod is a sidestream analyzer intended to provide a measurement of the following parameters: carbon dioxide (CO2); and respiratory rate.
The Qube displays information from the CapnoPod and is the user interface for the CapnoPod. The Qube provides a number display for CO2 and respiratory rate, and a capnograph waveform. The CapnoPod is intended to be used primarily in the operating room environment.
Intended Use: The Spacelabs Healthcare Capnography Pod, Model 92516 (CapnoPod) is intended to provide a means of monitoring carbon dioxide and respiration rate and alert clinical personnel when the concentration moves outside of user-defined limits.
The CapnoPod is intended to be used with and controlled by a Spacelabs Healthcare monitors. The CapnoPod is intended to be used for monitoring adult, pediatric and neonate patients, under the direction of qualified medical personnel.
Technology Comparison:
The CapnoPod employs the same technological characteristics as the predicate device.
| Characteristic | Predicate Device | Proposed Device |
|---|---|---|
| Parameters | Carbon dioxide (CO₂); oxygen (O₂) and | |
| nitrous oxide (N₂O); anesthetic agents | ||
| including: desflurane, enflurane, | ||
| halothane, isoflurane, and sevorflurane; | ||
| respiratory rate; and calculated MAC | ||
| and age-dependent MAC values. | Carbon dioxide (CO₂); and | |
| respiratory rate. | ||
| EtCO₂ | Yes | Same |
| FiCO₂ | Yes | Same |
| Measurement | ||
| Technology | Infrared Sensor | Same |
| Sampling | ||
| Technique | Sidestream | Same |
| Respiration Rate | ||
| (RR) Range | 4 to 60 breaths per minute (bpm) | 1.5 to 150 bpm |
| RR Accuracy | $\u00b1$ 1 bpm | Same |
2
510(k) Summary i
Summary of Performance Testing:
| Electrical Safety | The CapnoPod was tested for performance in accordance with the
following Standards:
IEC 60601-1: 1988, Am1: 1991, Am2: 1995, Medical electrical
equipment - Part 1. General requirements for safety; and UL 60601-1: 2003, Medical electrical equipment - Part 1. General
requirements for safety. Test results indicated that the CapnoPod complies with the Standards. |
|---------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Electromagnetic
Compatibility (EMC)
Testing | The CapnoPod was tested for performance in accordance with the
following Standard:
IEC 60601-1-2: 2007, Medical electrical equipment - Part 1-2:
General requirements for basic safety and essential performance –
Collateral standard: Electromagnetic compatibility – Requirements
and tests. Test results indicated that the CapnoPod complies with the Standards. |
| Software Testing | Software device modifications made to the CapnoPod were designed
and developed according to a robust software development process, and
were rigorously verified and validated.
Software information is provided in accordance with internal
documentation and the following Standards and guidance documents: FDA guidance: The content of premarket submissions for software
contained in medical devices, 11 May 05; FDA guidance: Off-the-shelf software use in medical devices, 09
Sep 99; FDA guidance: General principles of software validation; Final
guidance for industry and FDA staff, 11 Jan 02; IEC 60601-1-4: 2000, Medical electrical equipment Medical
electrical equipment - Part 1-4: General requirements for safety –
Collateral Standard: Programmable electrical medical systems. Test results indicate that the CapnoPod complies with its predetermined
specification and the Standards and guidance documents. |
3
510(k) Summary
| Performance Testing | The CapnoPod was tested for performance in accordance with internal documentation and the following Standards: | ||
|---|---|---|---|
| • | IEC 60601-1-8: 2006, Medical electrical equipment – Part 1-8: General requirements for basic safety and essential performance – Collateral Standard: General requirements, tests and guidance for alarm systems in medical electrical equipment and medical electrical systems; and | ||
| • | ISO 21647: 2004, Medical electrical equipment – Particular requirements for the basic safety and essential performance of respiratory gas monitors. | ||
| Test results indicated that the CapnoPod complies with its |
Test results indicated that the CapnoPod complies with its predetermined specification and with the applicable Standards.
Conclusion
Verification and validation activities were conducted to establish the performance and safety characteristics of the software device modifications made to the CapnoPod. The results of these activities demonstrate that the CapnoPod is safe and effective when used in accordance with its intended use and labeling.
Therefore, the CapnoPod is considered substantially equivalent to the predicate device.
4
Image /page/4/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings outstretched, enclosed within a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged around the circumference of the circle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Spacelabs Healthcare C/O Mr. Thomas Kroenke Principal Consultant Speed To Market, Incorporated P.O. Box 3018 Nederland. Colorado 80466
JUL 30 2012
Re: K121017
Trade/Device Name: Spacelabs Healthcare Capnography Pod (92516) Regulation Number: 21 CFR 868.1400 Regulation Name: Carbon Dioxide Gas Analyzer Regulatory Class: II Product Code: CCK Dated: June 13, 2012 Received: June 15, 2012
Dear Mr. Kroenke:
This letter corrects our substantially equivalent letter of July 13, 2012.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 - Mr. Kroenke
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely vours.
h for
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Indications for Use
| 510(k) Number (if known): | K121017 |
|---|---|
| Device Name: | Spacelabs Healthcare Capnography Pod (92516) |
| Indications for Use: | The Spacelabs Healthcare Capnography Pod, Model 92516 |
| (CapnoPod) is intended to provide a means of monitoring carbon | |
| dioxide and respiration rate and alert clinical personnel when the | |
| concentration moves outside of user-defined limits. |
The CapnoPod is intended to be used with and controlled by a
Spacelabs Healthcare monitors. The CapnoPod is intended to be
used for monitoring adult, pediatric and neonate patients, under
the direction of qualified medical personnel. |
Prescription Use ਮ (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
CDRH, Office of Device
(Division Sign-Off) (Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: _
Page 1 of 1